BMO Capital Downgrades Clorox (CLX) to Market Perform
More News related to CLX
- Clorox Announces Pricing of $300 Million Senior Notes
- The Clorox Company Joins the Business Coalition for Workplace Fairness
- The Makers of Clorox(R) Clean-Up(R) to Award $50,000 to Kids' Programs Through New Power A Bright Future Grant Program
- Clorox (CLX) Benefits In Q1 From H1N1 Fears (Update)
- Clorox (CLX) Tops Q1 EPS Views; Guides In-Line
More News related to Downgrades
- Morgan Stanley Downgrades AXA to Equalweight
- J.P. Morgan Downgrades RHI Entertainment (RHIE) to Neutral
- Oppenheimer Downgrades Adobe (ADBE) to Market Perform
- Morgan Keegan Downgrades Synovus Financial (SNV) to Market Perform
- JPMorgan Downgrades Tyson (TSN) to Neutral, $12 Target
BMO Capital downgrades Clorox (NYSE: CLX) from Outperorm to Market Perform with a $61 price target.
The Clorox Company manufactures and markets a range of consumer products, including bleaches, stain removers, sanitizing sprays and others.
Related Categories
DowngradesStocks Mentioned
+0.00Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
